Search

Displaying results 3741 - 3750 of 10000 in total
  1. Drug

    Piragliatin

    go.drugbank.com/drugs/DB20515
    Experimental

    The usage of the INN stem '-gliatin' in the name indicates that Piragliatin is a glucokinase activator. Piragliatin has a monoisotopic molecular weight of 421.09 Da.

  2. Drug

    Phenacaine

    go.drugbank.com/drugs/DB21274
    Experimental

    The usage of the INN stem '-caine' in the name indicates that Phenacaine is a local anaesthetic. Phenacaine has a monoisotopic molecular weight of 298.17 Da.

  3. Drug

    Uldazepam

    go.drugbank.com/drugs/DB21290
    Experimental

    The usage of the INN stem '-azepam' in the name indicates that Uldazepam is a diazepam derivative. Uldazepam has a monoisotopic molecular weight of 359.06 Da.

  4. Drug

    Fluradoline

    go.drugbank.com/drugs/DB21333
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Fluradoline is a analgesic. Fluradoline has a monoisotopic molecular weight of 301.09 Da.

  5. Drug

    Pinoxepin

    go.drugbank.com/drugs/DB21397
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Pinoxepin is a tricyclic compound. Pinoxepin has a monoisotopic molecular weight of 398.18 Da.

  6. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  7. Drug

    NS-2359

    go.drugbank.com/drugs/DB05805
    Investigational

    This mode of action is expected to produce an optimal reduction in all disease symptoms and the possibility of an earlier onset of action compared to antidepressants already on the market.

  8. Drug

    Guselkumab

    go.drugbank.com/drugs/DB11834
    ApprovedInvestigational

    In clinical trials, guselkumab demonstrated improved skin clearance and symptomatic improvements in dermatological manifestations of psoriasis. … IL-23 is an inflammatory cytokine that activates the CD4+ T-helper (Th17) cell pathway to mediate the inflammatory cascade that induces psoriatic plaque formation [A20357].

    Products: TREMFYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML, TREMFYA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/1ML
  9. Drug

    Carteolol

    go.drugbank.com/drugs/DB00521
    Approved

    A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

  10. Drug

    Alpibectir

    go.drugbank.com/drugs/DB21561
    Investigational

    Alpibectir has a monoisotopic molecular weight of 332.1 Da. … Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).